<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether impaired cardiovascular autonomic function correlates with <z:mp ids='MP_0002871'>albuminuria</z:mp> in an age-, sex-, and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance-stratified sample of an elderly (50-75 years of age) Caucasian population and to determine whether this association is independent of other determinants of <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We studied 536 subjects, 256 with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, 143 with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), and 137 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0002959'>Microalbuminuria</z:mp> was defined as an albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio of &gt; or =3.0 and &lt; or =30 mg/mmol in an early morning urine sample </plain></SENT>
<SENT sid="3" pm="."><plain>We used the deep-breathing test and the lying-to-standing test to obtain 4 measurements of cardiovascular autonomic function: 1) the heart rate (HR) variability during deep breathing, 2) the maximum HR within 15 s after standing up minus the mean HR before standing, 3) the maximum R-R interval between 15 and 30 s after standing up divided by the minimum R-R interval within 15 s after standing up, and 4) the systolic blood pressure in response to standing up </plain></SENT>
<SENT sid="4" pm="."><plain>These 4 measurements were summarized in a single cardiovascular autonomic function score (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CAFS</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 38 subjects with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and 3 subjects with macroalbuminuria (&gt;30 mg/mmol) were grouped as having <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>In bivariate analyses, <z:mp ids='MP_0002871'>albuminuria</z:mp> was associated with age, waist-to-hip ratio, systolic and diastolic blood pressure, calculated glomerular filtration rate, and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status </plain></SENT>
<SENT sid="7" pm="."><plain>The mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CAFS</z:e> was higher in subjects with versus without <z:mp ids='MP_0002871'>albuminuria</z:mp> (7.5 vs. 5.9, P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple logistical regression analyses revealed that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CAFS</z:e> was independently associated with <z:mp ids='MP_0002871'>albuminuria</z:mp> in subjects with IGT or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with an odds ratio (95% CI) of 1.19 (1.02-1.39) per point increase in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CAFS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Impaired cardiovascular autonomic function is independently associated with (and thus a possible contributor to) the presence of <z:mp ids='MP_0002871'>albuminuria</z:mp> in subjects with IGT or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>